A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Oral Corticosteroid Dependent Asthma (TROPOS)

Condition:   Oral Corticosteroid Dependent Asthma
Interventions:   Biological: Tralokinumab;   Other: Placebo
Sponsor:   AstraZeneca
Not yet recruiting – verified October 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days